[Federal Register Volume 83, Number 119 (Wednesday, June 20, 2018)]
[Notices]
[Page 28663]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-13223]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Registrants listed below have applied for and been granted 
registration by the Drug Enforcement Administration (DEA) as bulk 
manufacturers of various classes of schedule I and II controlled 
substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be 
registered as bulk manufacturers of various basic classes of controlled 
substances. Information on previously published notices is listed in 
the table below. No comments or objections were submitted for these 
notices.

------------------------------------------------------------------------
              Company                  FR Docket          Published
------------------------------------------------------------------------
AMRI Rensselaer, Inc..............      83 FR 5808  February 9, 2018.
Stepan Company....................      83 FR 9029  March 2, 2018.
Research Triangle Institute.......     83 FR 10523  March 9, 2018.
Rhodes Technologies...............     83 FR 12407  March 21, 2018.
Synthcon, LLC.....................     83 FR 13141  March 27, 2018.
National Center for Natural            83 FR 13522  March 29, 2018.
 Products--Research NIDA MPROJECT.
Insys Manufacturing LLC...........     83 FR 13522  March 29, 2018.
Navinta LLC.......................     83 FR 13521  March 29, 2018.
------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of these registrants to manufacture 
the applicable basic classes of controlled substances is consistent 
with the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated each of the company's maintenance of 
effective controls against diversion by inspecting and testing each 
company's physical security systems, verifying each company's 
compliance with state and local laws, and reviewing each company's 
background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer 
to the above listed companies.

    Dated: June 12, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-13223 Filed 6-19-18; 8:45 am]
BILLING CODE 4410-09-P